This toolkit aims to support other stakeholders, actors and researchers in the drugs field to implement their own foresight exercise in the form of an introductory trend-based workshop. This approach was chosen as a result of the experiences gained through the EMCDDA’s own foresi...
The purpose of the report is to provide information on access to healthcare in Nigeria. This information is relevant to the application of international protection status determination (refugee status and subsidiary protection) and migration legislation in EU+ countries. In addit...
The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all t...
This annex presents, in detail, the implementation of the EMCDDA’s work programme by objectives and expected outputs/results, in order to provide a clear picture of the work carried out by the agency in 2021. The EMCDDA achieved 82 % of outputs/results in the 2021 work programme ...
This report provides an overview of the latest tuberculosis (TB) epidemiological situation and is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control (ECDC). It finds a sharp 24% drop in notified new and relapse TB ca...
Antimicrobial resistance (AMR) remains a major public health concern in the WHO European Region, with estimates from the European Union/European Economic Area (EU/EEA) alone showing that each year more than 670 000 infections are due to bacteria resistant to antibiotics and appro...
On 17 June 2020, the European Commission presented the EU Vaccines Strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19. Objectives of the EU Vaccines Strategy are ensuring the quality, safety and efficacy of vaccines, securing timely ...
On 17 June 2020, the European Commission presented the EU Vaccines Strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19. Objectives of the EU Vaccines Strategy are ensuring the quality, safety and efficacy of vaccines, securing timely ...
COVID-19 has underlined the fact that in a context of recurring pandemics, public health is a basic global public good, the provision of which presupposes effective and timely collective action at global level. In this context, this paper positions global public health governance...